India's pharmaceutical sector must evolve beyond its traditional strength in generic medicines and build capabilities in complex generics, biologics, and research-driven drug development — that was the core message from…
India's pharmaceutical regulatory landscape is undergoing significant transformation. In January 2026, the Government of India notified key amendments to the New Drugs & Clinical Trials (NDCT) Rules, introducing changes that…
The Central Drugs Standard Control Organization (CDSCO) has moved to curb a widespread but problematic practice in India's pharmaceutical market: using the same brand name across multiple, unrelated drug products…
India's pharmaceutical export landscape is preparing for a landmark event. The 12th edition of iPHEX 2026 — India's largest international pharmaceutical exhibition — is set to bring together over 600…